The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

<p>Concomitant medication (CM) use may result in Phase I cancer clinical trial ineligibility due to concern for potential CM-investigational drug interactions or alteration of investigational drug absorption. Few studies have examined the impact of CM use on trial eligibility. <b>Methods...

Full description

Bibliographic Details
Main Author: Mitesh J. Borad, Kelly K. Curtis, Hani M. Babiker, Martin Benjamin, Raoul Tibes, Ramesh K. Ramanathan, Karen Wright, Amylou C. Dueck, Gayle Jameson, Daniel D. Von Hoff
Format: Article
Language:English
Published: Ivyspring International Publisher 2012-01-01
Series:Journal of Cancer
Online Access:http://www.jcancer.org/v03p0345.htm

Internet

http://www.jcancer.org/v03p0345.htm

Similar Items